role of echo in connective tissue diseases 고신 의대 내과 주 승 재
Post on 18-Dec-2015
214 Views
Preview:
TRANSCRIPT
Role of Echo inConnective Tissue Diseases
고신 의대 내과
주 승 재
Connective Tissue Diseases
• Systemic lupus erythematosus
• Antiphospholipid antibody syndrome
• Ankylosing spondylitis
• Rheumatoid arthritis
• Scleroderma
• Polymyositis and dermatomyositis
• Mixed connective tissue disease
Cardiac Diseases in Pts with SLE• Pericardial disease
Pericarditis
• Valvular disease Fibrin deposits (Libman-Sacks) Fibrous thickening of leaflets and chordae Valvular regurgitation and/ or stenosis Infective endocarditis
• Coronary artery diseases
• Myocardial diseae
• Hypertrophy
• Meta-analysis of 26 studies (Mayo Clin Proc 1999;74:255)
Clinical or echo prevalence 595/2,147 (28%) Autopsy prevelence
188/291 (65%) Cardiac tamponade
16/2,147 (0.7%)
• Echo prevalence 22 – 54% (Control; 0 – 10%)
Prevalence of Pericarditis in Pts with SLE
• Valve masses or
Libman-Sacks vegetation
• Leaflet thickening
• Valvular regurgitation
• Valvular stenosis
Valvular Disease Associated with SLE
Libman-Sacks Vegetation
• Prevalence
TTE; 10%, TEE; 30%
• Mitral and aortic valves
• < 1 cm2 in size
• Irregular borders
• Heterogenous echo density
• No independent motion
• Associated with thickening or regurgitation
Cauliflower-like or flat, red multiple spreading masses of 2 – 4 mm in diameter present on the free margins or line of closure of the heart valve
Echo findings
(Cardiol Clin 1998;16;531)
Libman-Sacks Vegetation and MR
• Valve thickness > 3 mm for MV and TV> 2 mm for AV
• PrevalenceTTE; 30%, TEE; 50%
• Mitral and aortic valves• Generally diffuse but predominant on the mid and t
ip portions• Commonly associated with valve regurgitation or v
alve masses or both• Valve stenosis is rare (<3%).• Leaflet calcification is uncommon.• Involvement of the annular and subvalvular appara
tus is rare (1%).
Abnormal Leaflet Thickening in SLE
• The most frequent abnormality (up to 79%)
• Moderate-to-severe regurgitation in 7% to 41%
• MV>TV>AV>PV
• Moderate or severe regurgitation is almost always accompanied by leaflet thickening.
Valvular Regurgitation in SLE
Differential Diagnosis Libman-Sacks vegetation
• Infective endocarditis (IE) Vibratory or rotatory motion independent of t
he leaflet motion
• Pseudoinfective endocarditis A clinical syndrome of active SLE mimics IE. Low WBC count
Elevation of antiphospholipid Ab
Negative or low positive CRP
• Rheumatic valvular disease Leaflet thickening localized to the leaflet tips
Chordal thickening, fusion, tethered motion and calcification
• Age-related valvular disease Valve sclerosis is marked in the valve annulus.
Frequently associated with calcification
Differential Diagnosis Abnormal Leaflet Thickening in SLE
Evolution of Valvular Disease in SLE Resolve (24%), appear de novo (12%), or
persist but change over time (40%)
Initial 2 mon later 20 mon later
(NEJM 1996;335:1424)
Clinical Course of Pts with SLE and Valvular DIsease
• Neither the presence nor the changes over time in valvular disease were temporarily associated with pt’s age or with the duration, activity, severity, or therapy of SLE
• 21% incidence of valve-related complications with a 5-yr F/U Symptomatic severe valvular regurgitation Infective endocarditis Ischemic stroke
Vegetation, valvulitis, and LA thrombus in 70 to 90%
• Mortality 20% at 5 yrs Causes of death
Refractory HF, infective endocarditis, complicated postoperative course and CVA
• Prosthetic valve replacement or valve repair
Higher morbidity and mortality of valve replacement
• Steroid or cytotoxic therapy has no effect on the presence or the evolution of SLE-associated valvular disease
• Antibiotic prophylaxis for dental or nonsterile procedures
• Antiplatelet therapy
Therapy of Pts with SLE and Valvular Disease
Antiphospholipid Antibody Syndrome• Venous or arterial thrombosis, recurrent fetal los
s, or thrombocytopenia accompanied by an increased levels of antiphospholipid Ab (aPLs)
• Primary or secondary (SLE)• Valvular lesions
Vegetation, thickening, or regurgitation Prevalence 32% to 38% in primary APS A significantly higher prevalence of valvular defects i
n SLE pts with aPLs
• Therapy Long-term, high intensity oral anticoagulation (INR 3)
Aortic Root Disease and Valve Disease Associated with Ankylosing Spondylitis
• Pathology The inflammatory process predominantly of the adventiti
a and intima of the aortic root results in a fibroblastic reparative response and vascularized fibrous tissue thickening
• Aortic valvulitis Cusp thickening and retraction Thickening of the aorto-mitral junction or subaortic bump Proximal aortitis leading to aortic root thickening and dila
tion Aortic and mitral regurgitation
• Prevalence Autopsy studies; 24 to 100% Echo studies
TTE; 8 to 31%TEE; 82% (control; 27%)
• Echo findings Nonspecific thickening of aortic and mitral valves Increased echogenicity of the posterior aortic wa
ll and membraneous interventricular septum Mild-to-moderate aortic regurgitation
Aortic Root Disease and Valve Disease Associated with Ankylosing Spondylitis
TEE findings Aortic root
Thickening; 61%
Increased stiffness; 61%
Dilatation; 25% Valve thickening
aortic valve 41%, mitral valve 34%
Nodularities of the aortic cusp and basal thickening of the anterior mitral valve leaflet (subaortic bump)
Valve regurgitation; 50% (moderate)
Aortic Root Disease and Valve Disease Associated with Ankylosing Spondylitis
(Roldan et al. JACC 1998;32:1397)
• No correlation with clinical features of AKS• Evolution (Roldan et al. JACC 1998;32:1397)
39-mon F/U of 25 patients New abnormalities; 6 (24%) Progression of valve regurgitation; 3 (12%) Resolved; 5 (20%)
• Therapy Questionable role of corticosteroid Aortic and mitral valve replacement in pts with sev
ere aortitis and valvular dysfunction Prophylactic antithrombotic therapy Antibiotic prophylaxis for infective endocarditis in p
ts with moderate valvular regurgitation
Aortic Root Disease and Valve Disease Associated with Ankylosing Spondylitis
Cardiac Disease Associated with Rheumatoid Arthritis
• Pericarditis Autopsy studies; 40% Echo studies; 50% Clinically significant pericardial effusion; < 3%
• Valvular heart disease
• Coronary arteritis
• Myocarditis
• Conduction disturbance
• Valvular diseases Valvular thickening Valvular regurgitation Valvular granulomas
• Prevalence Autopsy studies; 23 to 75% Echo studies
TTE; 30%
TEE; Thickening 66%
Valvular nodules 50%
Valvular regurgitation 13%
Valvular Heart Disease Associated with Rheumatoid Arthritis
• Unique to RA
• Small (<0.5 cm2)
• Oval in shape
• Well-defined border
• Homogenous reflectance
• Not calcified
• Usually single
Valvular Nodules Associated with Rheumatoid Arthritis
(Cardiol Clin 1998;16;531)
• Correlation with clinical features A higher prevalence of valvular disease in pts with er
osive polyarticular and nodular disease, systemic vascularitis, and high titers of RA factor
No association with the pt’s age, duration of RA, or peripheral nodular disease
• Therapy A few cases of significant improvement of severe val
vulitis with the use of steroids or cytotoxic therapy Mitral and aortic valve replacement in severe regurgi
tation
Valvular Heart Disease Associated with Rheumatoid Arthritis
• Pericarditis• Myocardial disease
Myocardial fibrosis, myocarditis CHF; 5%
• Conduction disturbance• Pulmonary hypertension
One of the major causes of death
• Valvular heart disease• Coronary artery disease
Cardiac Disease Associated with Scleroderma
• Limited echocardiographic data
• Nonspecific thickening of the mitral or aortic valve
• A high prevalence of MVP (67%)
• Aortic valvulitis with a perforated cusp and severe regurgitation
• Noninfective mitral valve vegetations similar to those of SLE
Valvular Heart Disease Associated with Scleroderma
(Cardiol Clin 1998;16;531)
• Myocarditis
• Pericarditis
• Mitral valve prolapse; up to 50%
Cardiac Disease Associated with Polymyositis and Dermatomyositis
• Pericarditis
• Pulmonary hypertension and
cor pulmonale
• Mitral valve prolapse; up to 32%
• Verrucous thickening of the mitral valve and mitral regurgitation
Cardiac Disease Associated with Mixed Connective Tissue Disease
Summary• Valvular abnormalities unique to a specific disease
Libman-Sacks vegetation; SLE Valve nodules; RA Subaortic bump; AKS
• Differential diagnosis Infective endocarditis Rheumatic valvular disease Degenerative valvular disease
• Echocardiography, especially TEE, has the potential to redefine the prevalence rates and to characterize better the cardiac abnormalities associated with connective tissue diseases.
top related